Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis

Background: Tracheal replacement is a challenge for thoracic surgeons due to stenosis in the trachea-prosthesis anastomosis. We propose that stenosis occurs due to fibrosis as a result of an abnormal healing process, characterized by an increased expression of wound healing growth factors (vascular...

Full description

Bibliographic Details
Main Authors: J. Alfredo Santibáñez-Salgado, Avelina Sotres-Vega, Miguel O. Gaxiola-Gaxiola, Jaime Villalba-Caloca, Karen Bobadilla Lozoya, Joaquín A. Zúñiga-Ramos
Format: Article
Language:English
Published: Korean Society for Thoracic & Cardiovascular Surgery 2021-06-01
Series:Journal of Chest Surgery
Subjects:
id doaj-f8b643fa903747e6b58bfdae417b6142
record_format Article
spelling doaj-f8b643fa903747e6b58bfdae417b61422021-06-04T02:12:58ZengKorean Society for Thoracic & Cardiovascular SurgeryJournal of Chest Surgery2765-16062765-16142021-06-0154319119910.5090/jcs.20.146Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote StenosisJ. Alfredo Santibáñez-Salgado0https://orcid.org/0000-0002-7632-9158Avelina Sotres-Vega1https://orcid.org/0000-0002-1873-4243Miguel O. Gaxiola-Gaxiola2https://orcid.org/0000-0002-2945-9793Jaime Villalba-Caloca3https://orcid.org/0000-0001-9499-1930Karen Bobadilla Lozoya4https://orcid.org/0000-0001-9948-4065Joaquín A. Zúñiga-Ramos5https://orcid.org/0000-0002-7143-0281Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas”Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas”Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas”Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas”Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas”Tecnológico de MonterreyBackground: Tracheal replacement is a challenge for thoracic surgeons due to stenosis in the trachea-prosthesis anastomosis. We propose that stenosis occurs due to fibrosis as a result of an abnormal healing process, characterized by an increased expression of wound healing growth factors (vascular endothelial growth factor [VEGF], survivin, and CD31), which promote angiogenesis and decrease apoptosis. We analyzed the immunoreactivity of VEGF, survivin, CD31, and caspase-3 in the development of fibrotic stenosis in prosthetic tracheal replacement. Methods: Fourteen dogs were operated on: group I (n=7) received a 6-ring cervical tracheal segment autograft, while in group II (n=7), a 6-ring segment of the cervical trachea was resected and tracheal continuity was restored with a Dacron prosthesis. The follow-up was 3 months. Immunoreactivity studies for VEGF, survivin, CD31, and caspase-3 were performed. A statistical analysis was done using the Wilcoxon signed rank test. Results: Four animals in group I were euthanized on the 10th postoperative day due to autograft necrosis. Three animals completed the study without anastomotic stenosis. Moderate expression of VEGF (p=0.038), survivin (p=0.038), and CD31 (p=0.038) was found. All group II animals developed stenosis in the trachea-prosthesis anastomotic sites. Microscopy showed abundant collagen and neovascularization vessels. Statistically significant immunoreactive expression of VEGF (p=0.015), survivin (p=0.017), and CD31 (p=0.011) was observed. No expression of caspase-3 was found. Conclusion: We found a strong correlation between fibrosis in trachea-prosthesis anastomoses and excessive angiogenesis, moderate to intense VEGF, CD31, and survivin expression, and null apoptotic activity. These factors led to uncontrolled collagen production.tracheaprosthesisangiogenesisapoptosisfibrosis
collection DOAJ
language English
format Article
sources DOAJ
author J. Alfredo Santibáñez-Salgado
Avelina Sotres-Vega
Miguel O. Gaxiola-Gaxiola
Jaime Villalba-Caloca
Karen Bobadilla Lozoya
Joaquín A. Zúñiga-Ramos
spellingShingle J. Alfredo Santibáñez-Salgado
Avelina Sotres-Vega
Miguel O. Gaxiola-Gaxiola
Jaime Villalba-Caloca
Karen Bobadilla Lozoya
Joaquín A. Zúñiga-Ramos
Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis
Journal of Chest Surgery
trachea
prosthesis
angiogenesis
apoptosis
fibrosis
author_facet J. Alfredo Santibáñez-Salgado
Avelina Sotres-Vega
Miguel O. Gaxiola-Gaxiola
Jaime Villalba-Caloca
Karen Bobadilla Lozoya
Joaquín A. Zúñiga-Ramos
author_sort J. Alfredo Santibáñez-Salgado
title Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis
title_short Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis
title_full Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis
title_fullStr Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis
title_full_unstemmed Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis
title_sort experimental tracheal replacement: angiogenesis and null apoptosis promote stenosis
publisher Korean Society for Thoracic & Cardiovascular Surgery
series Journal of Chest Surgery
issn 2765-1606
2765-1614
publishDate 2021-06-01
description Background: Tracheal replacement is a challenge for thoracic surgeons due to stenosis in the trachea-prosthesis anastomosis. We propose that stenosis occurs due to fibrosis as a result of an abnormal healing process, characterized by an increased expression of wound healing growth factors (vascular endothelial growth factor [VEGF], survivin, and CD31), which promote angiogenesis and decrease apoptosis. We analyzed the immunoreactivity of VEGF, survivin, CD31, and caspase-3 in the development of fibrotic stenosis in prosthetic tracheal replacement. Methods: Fourteen dogs were operated on: group I (n=7) received a 6-ring cervical tracheal segment autograft, while in group II (n=7), a 6-ring segment of the cervical trachea was resected and tracheal continuity was restored with a Dacron prosthesis. The follow-up was 3 months. Immunoreactivity studies for VEGF, survivin, CD31, and caspase-3 were performed. A statistical analysis was done using the Wilcoxon signed rank test. Results: Four animals in group I were euthanized on the 10th postoperative day due to autograft necrosis. Three animals completed the study without anastomotic stenosis. Moderate expression of VEGF (p=0.038), survivin (p=0.038), and CD31 (p=0.038) was found. All group II animals developed stenosis in the trachea-prosthesis anastomotic sites. Microscopy showed abundant collagen and neovascularization vessels. Statistically significant immunoreactive expression of VEGF (p=0.015), survivin (p=0.017), and CD31 (p=0.011) was observed. No expression of caspase-3 was found. Conclusion: We found a strong correlation between fibrosis in trachea-prosthesis anastomoses and excessive angiogenesis, moderate to intense VEGF, CD31, and survivin expression, and null apoptotic activity. These factors led to uncontrolled collagen production.
topic trachea
prosthesis
angiogenesis
apoptosis
fibrosis
work_keys_str_mv AT jalfredosantibanezsalgado experimentaltrachealreplacementangiogenesisandnullapoptosispromotestenosis
AT avelinasotresvega experimentaltrachealreplacementangiogenesisandnullapoptosispromotestenosis
AT miguelogaxiolagaxiola experimentaltrachealreplacementangiogenesisandnullapoptosispromotestenosis
AT jaimevillalbacaloca experimentaltrachealreplacementangiogenesisandnullapoptosispromotestenosis
AT karenbobadillalozoya experimentaltrachealreplacementangiogenesisandnullapoptosispromotestenosis
AT joaquinazunigaramos experimentaltrachealreplacementangiogenesisandnullapoptosispromotestenosis
_version_ 1721398520819220480